3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Follicular
1
Asthma
1
Interventions
Fluticasone-Salmeterol Drug Combination
3
Fluticasone
2
laninamivir
1
fluticasone-formoterol
1
NVP-QAV680
1
Formoterol Fumarate
1
Etanercept
1
Drug Delivery Systems
1
CS 8958
1
Budesonide, Formoterol Fumarate Drug Combination
1
Budesonide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Asthma
×
Budesonide, Formoterol Fumarate Drug Combination
×
Clear all
NCT00646516
2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3
Completed
615 enrolled